Two Kansas State University biochemists have discovered a family of proteins that could lead to better treatments for Staphylococcus aureus, a pathogenic bacterium that can cause more than 60,000 potentially life-threatening infections each year.
Brian Geisbrecht, professor of biochemistry and molecular biophysics, and Kasra Ramyar, his research associate, are studying S. aureus, which is the cause of increasing common staph infections. Their work appears in the scientific journal Proceedings of the National Academy of Sciences of the United States of America, or PNAS, in the article "Staphylococcus aureus secretes a unique class of neutrophil serine protease inhibitors."
This drawing represents the crystal structure of the NSP neutrophil elastase, shown in blue, bound to the Staphylococcus aureus Eap protein, EapH1, shown in gold. Two Kansas State University biochemists have discovered that S. aureus secretes a family of proteins that prevent neutrophil serine proteases, or NSPs, from functioning — an important finding for understanding how infections are established.
While S. aureus is typically a harmless commensal organism found in the nose and skin of 30 percent of the human population, it can cause serious and deadly infections if it invades deeper tissues.
In their latest research, Geisbrecht, Ramyar and collaborators discovered that S. aureus secretes a family of proteins that prevent neutrophil serine proteases, or NSPs, from functioning — an important finding for understanding how infections are established. Neutrophils — the most abundant type of white blood cells — help prevent serious infections from occurring.
"Neutrophils are like the fire department of the immune system," Geisbrecht said. "They are the first on the scene when a microbial infection tries to take hold."
Neutrophils directly attack pathogens and emit biochemical signals that recruit other inflammatory immune cells to the site of infection when they release NSPs from intracellular granules.
"To our knowledge, Staph is the first example of any bacterium that secretes protease inhibitors specifically to block an aspect of the host immune response that is essential for its removal from the body," Geisbrecht said.
The research also may lead to better treatments for inflammatory conditions, such as emphysema and chronic obstructive pulmonary disease, which are the result of dysregulated neutrophil activation in the lung.
Geisbrecht and Ramyar have closely researched neutrophils because they are the first cells to respond to infections. The biochemists' discovery that that S. aureus secretes a family of proteins — called extracellular adherence proteins, or Eaps — that block NSPs could eventually affect how staph infections are treated in the clinic.
"Understanding this interaction can not only help us design better therapies in the future, but may help make current treatment regimens work better," Geisbrecht said.
Because these Eap proteins prevent neutrophils from working properly, they are essential for S. aureus to establish an infection.
"Our bodies respond vigorously to being invaded by S. aureus, and in order to prevent the infection from spreading, we have an arsenal of soluble molecules and white blood cells," Ramyar said. "That is our immune system, and neutrophils are a vital part of that."
The latest discovery puts a new twist on the past decades of research, which include studies that were done without a detailed molecular insight into how Eap proteins function. Geisbrecht, Ramyar and collaborators are now trying to better understand how their recent findings may affect interpretation of previous research.
"Bacterial pathogens like staph wouldn't be making these proteins if they weren't important to the context of infection," Geisbrecht said. "The bacteria are trying to shut off the inflammatory response and we should be paying attention to how they're doing it."
For this project, Kansas State University researchers collaborated with scientists from University Medical Center Utrecht in the Netherlands; Saarland University Medical Center in Germany; University of Veterinary Medicine in Hannover, Germany; and the University of Missouri, Kansas City.
The Kansas State University researchers provided experimental tools, biochemical information and the atomic resolution crystal structure of a complex formed between an S. aureus Eap protein and a human NSP. They received support from the National Institutes of Health.
Jennifer Tidball | Eurek Alert!
Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München
Second research flight into zero gravity
21.10.2016 | Universität Zürich
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences